bioRxivBioinformaticsPreprint
MultiAlloDriver: a multi-model method to predict and identify cancer driver mutations
Wanyao ZhouiD, Yuchengze SongiD, Jixiao HeiD, Mingyu LiiD, Jian ZhangiD, Shaoyong LuiD
Abstract
A minority of driver mutations in cancer significantly alter protein structure and key functionalities, thereby driving cancer progression. Consequently, the prediction and identification of driver mutations hold critical implications for targeted cancer therapy. This study introduces MultiAlloDriver, a novel multi-modal machine learning model based on an attention mechanism, which for the first time, incorporates protein surface information. By integrating information from three dimensions-protein sequence, structure, and surface-the model achieves high-accuracy driver target prediction with an accuracy exceeding 93%. Notably, we utilized this tool to predict and identify the driver effect of the F90S mutation in the PTEN tumor suppressor gene, uncovering mutations associated with cancer signaling mechanisms. Overall, MultiAlloDriver contributes to elucidating the underlying mechanisms of cancer development and progression, providing a robust framework for the identification of driver targets.
- assay: protein sequence
- assay: protein structure
- research focus: variant effect prediction
- approach: machine learning (classical)
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Machine learning predictions improve identification of real-world cancer driver mutations
Thinh Ngoc Tran, Chris Fong, … Justin Jee·bioRxiv·Mar 31, 2024
- Combining evolution and protein language models for an interpretable cancer driver mutation prediction with D2Deep
Konstantina Tzavella, Adrián Díaz, … Wim Vranken·Briefings in BioinformaticsPeer-reviewed·Nov 22, 2024
- Sequence neighborhoods enable reliable prediction of pathogenic mutations in cancer genomes
Shayantan Banerjee, Karthik Raman, Balaraman Ravindran·CancersPeer-reviewed·May 14, 2021
- An interpretable molecular framework for predicting cancer driver missense mutations
Yan Yang, Weikang Sun, … Minghui Li·Proceedings of the National Academy of SciencesPeer-reviewed·Feb 3, 2026
- Looking Across Protein Domains to Identify Driver Mutations in Cancer
Daria S. Ostroverkhova, Yiru Sheng, … Anna R. Panchenko·bioRxiv·Aug 11, 2025
- A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations
Paul Ashford, Camilla Pang, … Christine Anne Orengo·Scientific ReportsPeer-reviewed·Jan 22, 2019